# Which UK funds hold Medtronic plc. (MDT)?

**Source:** https://fundology.uk/stock/MDT · NYSE: MDT · Data: fund issuers' published holdings (dates differ by fund; newest 16/10/2026), company profile by TradingView

Medtronic plc. (MDT) is among the ten largest holdings of 2 UK funds Fundology covers, according to the holdings each fund publishes. In the largest of these funds by size, it makes up 1.87% of USDV (State Street SPDR S&P US Dividend Aristocrats UCITS ETF USD) and 10.02% of CYBG (VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD). The largest weight is 10.02%, in CYBG (VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD), as of 16/10/2026. In all, 161 funds list it among their published holdings. 11 swap-based funds also list Medtronic plc. (MDT) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.

## Funds where Medtronic plc. is one of the ten largest holdings

2 funds, largest weight first. A weight is the share of the fund's money in this company, as of the date of that fund's published holdings.

| Fund | Ticker | ISIN | Weight in the fund | Holdings as of |
|---|---|---|---|---|
| [VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD](https://fundology.uk/fund/cybg) | CYBG | IE0005TF96I9 | 10.02% | 16/10/2026 |
| [State Street SPDR S&P US Dividend Aristocrats UCITS ETF USD](https://fundology.uk/fund/usdv) (2 share classes, one portfolio) | USDV | IE00B6YX5D40 | 1.87% | 15/10/2026 |

159 more funds list Medtronic plc. below their ten largest holdings. Each fund page shows its ten largest holdings to everyone; the full lists need a free account.

Holdings come from the issuers that publish them. Some publish only their ten largest positions, so a fund can hold this company without appearing here. Index funds hold companies roughly in proportion to their size in the index, so the largest companies appear in many funds at similar weights.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.